一种用于法国职业环境中的化学风险评估的控制带方法
Abir Aachimi1,2,3, Florian Marc2, Nathalie Bonvallot3
1Department of Pollutant Metrology, Institut National de Recherche et de Sécurité (INRS), Paris, France.
Frontiers in public health
|December 28, 2023
概括
这项研究引入了一种控制-绑定方法,使公司能够评估职业化学风险,优先考虑对工人的安全进行干预. 赛里奇工具帮助工业卫生专家管理化学物质暴露和实施预防措施.
科学领域:
- 职业健康 职业健康 职业健康
- 工业卫生 工业卫生
- 化学品风险评估 化学品风险评估
背景情况:
- 评估产品和排放的职业化学风险对于公司的安全至关重要.
- 目前的方法需要解决吸入和皮肤暴露的途径.
- 工业卫生师需要实用工具来进行公司级风险评估.
研究的目的:
- 为公司提供一种新的方法来评估化学职业风险.
- 帮助工业卫生专家优先考虑降低风险的干预措施.
- 将吸入和皮肤暴露途径纳入风险评估.
主要方法:
- 采用一个控制-捆绑方案,根据暴露参数和产品危害对工作情况进行分类.
- 参数被赋予以整数值的"频段";乘法得到一个风险得分.
- 评分被转换成颜色编码的优先级带 (红色,色,绿色) 进行干预.
主要成果:
- 该方法提供了一种系统的方法,以优先考虑公司内的化学风险干预措施.
- 一个法国立面绝缘公司的案例研究表明了该方法的应用.
- 优先级系统有助于识别需要采取替代或通风等预防措施的区域.
结论:
- 开发的Seirich工具促进了这种风险评估方法的实际实施.
- 该工具促进了工业卫生专家在化学风险管理方面的最佳实践.
- 这种方法支持在法国减少化学风险的干预措施的有效优先级.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
01:12Hazard Ratio
129
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
129